This page shows the latest MabThera news and features for those working in and with pharma, biotech and healthcare.
Revlimid (lenalidomide) has been recommended for use with Roche’s MabThera (rituximab) – also known as R2 regimen – for the treatment of adult patients with previously-treated grade 1 to 3A follicular ... Revlimid plus MabThera demonstrated a
All told, the Swiss group’s pharma sales came in at CHF 12bn ($12.35bn), with its ‘big three’ antibodies – Avastin (bevacizumab), Herceptin (trastuzumab) and Rituxan/MabThera (rituximab) – all on the
Alongside Herceptin, this includes Avastin (bevacizumab) and MabThera (rituximab) which are also under threat from new biosimilar launches.
At the moment ANCA vasculitis is treated with a combination of potent steroids like prednisolone with immunosuppressive drugs like cyclophosphamide or Roche’s Rituxan/MabThera (rituximab).
Roche has been counting on a new class of medicines to help offset the biosimilar onslaught on its ageing cancer blockbusters, including Herceptin and MabThera/Rituxan.
This was all achieved despite heavy erosion of sales in Europe thanks to biosimilars - the group's total sales fell 4% in the region, with Herceptin revenues down 45% and
More from news
Approximately 17 fully matching, plus 110 partially matching documents found.
Humira remains at the top, but Celgene’s Revlimid has jumped ahead of Roche’s Avastin, MabThera and Herceptin.
We are starting to see more deals covering biosimilars and this month Poland-based Mabion signed a supply and commercialisation agreement with Mylan for a biosimilar of Roche's ... competitors. The patents covering MabThera/Rituxan expired in Europe in
Roche has two products approved in Europe, Herceptin SC and MabThera SC, and Baxter has HyQvia approved in the US and EU, which utilise the Halozyme approach. ... Herceptin SC and MabThera SC can be administered in approximately 5 minutes by sc injection
For example, in autumn 2014, BIOCAD fully pushed out Roche's Mabthera (rituximab) from public procurement.
Subcutaneous formulations of both MabThera and Herceptin based on the Halozyme technology have been launched by Roche.
More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.
He gradually rose up the ranks at Roche, holding senior marketing positions such as life cycle leader for both MabThera and Xeloda, head of oncology and chief marketing officer, before taking
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Herceptin, Avastin, Rituximab and Erbitux) and autoimmune disease (e.g. Humira, Enbrel, Remicade, MabThera and RoActemra to name a few).
The greatest attraction, naturally, is high-revenue anti-TNF agents like MabThera (rituximab) and Humira (adalimumab), for many years the world's most valuable drug.
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....